K＆Oエナジーグループ＜1663＞ 3720 -60Stock Name Closing Price on Day 7 ⇒ Comparison with Previous Day
Irex <9517> 739 -20
There is a sense of a cycle in the rapid rebound.
K&O Energy Group <1663> 3720 -60
Sell orders are gathered in Perovskite-related stocks on the 7th.
Kawasaki Kisen <9107> 2229 -62.5
In the strong-moving Marine Shipping stocks on the 6th, profit-taking sales are predominant.
Renova <9519> 768 -29
Strong movements were notably seen in renewable energy-related sectors leading up to the 6th.
ACCESS <4813> 906 -27
Although it saw a significant rise on the 6th, there was a sell-off at the 25-day moving average level.
Technisco <2962> 333 +80
Nothing noteworthy, just some speculative movements.
NF HD <6864> 1530 +300
Interest is turning towards Quantum Computing related fields.
Liberta <4935> 6390 +1000
The movements for short-term profit taking continue due to speculation.
Japan Rad <4736> 1010 +150
Movement for profit taking is seen in Quantum Computing related fields.
Muromachi Chemical <4885> 1131 +150
Being bought as part of measures related to 'PFAS'.
J.E.T <6228> 1440 +229
Riding the wave of rising Semiconductor related Stocks.
Metaplanet <3350> 3775 +200
Taking note of the rise in Bitcoin prices.
REVOLUTION <8894> 380 +29
Aiming for a rebound from the feeling of adjustment coming to an end.
Daiichi Pan <2215> 633 +66
Appears to have been featured in some Broadcasting.
FDK <6955> 602 +72
M&A of Fujitsu General stimulated the market.
GFA <8783> 567 +47
After adjusting to the 25-day line, there is a rebound movement.
Iseka <4107> 30250 -2550
The perovskite-related stocks were generally weak on the 7th.
Renascience <4889> 311 +12
Phase 3 trials for melanoma treatment have been approved by Tohoku University Ethics Review Board.
Buying ahead, but resistance is strong.
Rakuoria Pharmaceuticals <4579> 404 +24
A sub-license agreement for the gastric acid secretion inhibitor tegoprazan in Australia and New Zealand.
Sub-license agreement.
Modalis <4883> 103 -6
JCR Pharma <4552> became popular on the 6th due to a joint research contract, but there was a long upper shadow.
On the 7th, selling is dominant.
CANBAS <4575> 929 +42
免疫系抗がん剤候補化合物CBT005に関し米国で特許査定。
247＜7074＞ 351 -53
The reactionary decline from the limit high on the 6th.
Jiban Network HD <6072> 190 +1
一般社団法人ハウスワランティの「地盤調査・解析・保証及び各種
コンサルタント等」事業を取得。
Skymark <9204> 624 +22
Sojitz is expected to acquire 5% of the stocks and become a major shareholder, purchased on the 6th. Remains strong on the 7th.
Headwater <4011> 5640 +20
Started offering AI agent solutions.
Although it was temporarily bought, the upper prices are heavy.
Kauris <153A> 1468 +67
Officially released the 'Fraud Alert Deposit and Withdrawal Detection' service that monitors deposits and withdrawals.
Official release.
Kaiomu <4583> 263 -6
Joint research results related to antibody technology with the University of Tokyo were presented at a U.S. academic conference.
It starts rising but then loses momentum.
